---
document_datetime: 2025-12-02 05:27:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/ristempa.html
document_name: ristempa.html
version: success
processing_time: 0.0893702
conversion_datetime: 2025-12-24 22:02:37.198165
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Ristempa

[RSS](/en/individual-human-medicine.xml/66026)

##### Withdrawn

This medicine's authorisation has been withdrawn

pegfilgrastim Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Ristempa](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 28 September 2017 the European Commission withdrew the marketing authorisation for Ristempa (pegfilgrastim) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Amgen Europe B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Ristempa was granted marketing authorisation in the EU on 13 April 2015 for the treatment of neutropenia.

Ristempa was a duplicate application to Neulasta, which is marketed in several EU countries. The marketing authorisation holder will maintain the marketing authorisation for Neulasta.

The European Public Assessment Report (EPAR) for Ristempa is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Ristempa : EPAR - Summary for the public

English (EN) (1.39 MB - PDF)

**First published:** 16/04/2015

**Last updated:** 07/03/2018

[View](/en/documents/overview/ristempa-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-299)

български (BG) (596.74 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/bg/documents/overview/ristempa-epar-summary-public_bg.pdf)

español (ES) (518.95 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/es/documents/overview/ristempa-epar-summary-public_es.pdf)

čeština (CS) (573.94 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/cs/documents/overview/ristempa-epar-summary-public_cs.pdf)

dansk (DA) (518.15 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/da/documents/overview/ristempa-epar-summary-public_da.pdf)

Deutsch (DE) (514.2 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/de/documents/overview/ristempa-epar-summary-public_de.pdf)

eesti keel (ET) (517.48 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/et/documents/overview/ristempa-epar-summary-public_et.pdf)

ελληνικά (EL) (600.7 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/el/documents/overview/ristempa-epar-summary-public_el.pdf)

français (FR) (513.57 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/fr/documents/overview/ristempa-epar-summary-public_fr.pdf)

hrvatski (HR) (534.56 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/hr/documents/overview/ristempa-epar-summary-public_hr.pdf)

italiano (IT) (517.19 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/it/documents/overview/ristempa-epar-summary-public_it.pdf)

latviešu valoda (LV) (573.72 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/lv/documents/overview/ristempa-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (535.48 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/lt/documents/overview/ristempa-epar-summary-public_lt.pdf)

magyar (HU) (570.33 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/hu/documents/overview/ristempa-epar-summary-public_hu.pdf)

Malti (MT) (575.73 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/mt/documents/overview/ristempa-epar-summary-public_mt.pdf)

Nederlands (NL) (518.16 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/nl/documents/overview/ristempa-epar-summary-public_nl.pdf)

polski (PL) (574.3 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/pl/documents/overview/ristempa-epar-summary-public_pl.pdf)

português (PT) (517.7 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/pt/documents/overview/ristempa-epar-summary-public_pt.pdf)

română (RO) (534.55 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/ro/documents/overview/ristempa-epar-summary-public_ro.pdf)

slovenčina (SK) (1.02 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/sk/documents/overview/ristempa-epar-summary-public_sk.pdf)

slovenščina (SL) (568.91 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/sl/documents/overview/ristempa-epar-summary-public_sl.pdf)

Suomi (FI) (512.8 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/fi/documents/overview/ristempa-epar-summary-public_fi.pdf)

svenska (SV) (512.44 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/sv/documents/overview/ristempa-epar-summary-public_sv.pdf)

Ristempa : EPAR - Risk-management-plan summary

English (EN) (1.4 MB - PDF)

**First published:** 15/04/2015

**Last updated:** 07/03/2018

[View](/en/documents/rmp-summary/ristempa-epar-risk-management-plan-summary_en.pdf)

## Product information

Ristempa : EPAR - Product Information

English (EN) (2.56 MB - PDF)

**First published:** 16/04/2015

**Last updated:** 07/03/2018

[View](/en/documents/product-information/ristempa-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-475)

български (BG) (2.31 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/bg/documents/product-information/ristempa-epar-product-information_bg.pdf)

español (ES) (1.41 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/es/documents/product-information/ristempa-epar-product-information_es.pdf)

čeština (CS) (2.14 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/cs/documents/product-information/ristempa-epar-product-information_cs.pdf)

dansk (DA) (1.45 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/da/documents/product-information/ristempa-epar-product-information_da.pdf)

Deutsch (DE) (1.39 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/de/documents/product-information/ristempa-epar-product-information_de.pdf)

eesti keel (ET) (1.29 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/et/documents/product-information/ristempa-epar-product-information_et.pdf)

ελληνικά (EL) (2.54 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/el/documents/product-information/ristempa-epar-product-information_el.pdf)

français (FR) (1.46 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/fr/documents/product-information/ristempa-epar-product-information_fr.pdf)

hrvatski (HR) (1.43 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/hr/documents/product-information/ristempa-epar-product-information_hr.pdf)

íslenska (IS) (915.98 KB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/is/documents/product-information/ristempa-epar-product-information_is.pdf)

italiano (IT) (1.49 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/it/documents/product-information/ristempa-epar-product-information_it.pdf)

latviešu valoda (LV) (2.02 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/lv/documents/product-information/ristempa-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.57 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/lt/documents/product-information/ristempa-epar-product-information_lt.pdf)

magyar (HU) (2.14 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/hu/documents/product-information/ristempa-epar-product-information_hu.pdf)

Malti (MT) (2.13 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/mt/documents/product-information/ristempa-epar-product-information_mt.pdf)

Nederlands (NL) (1.48 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/nl/documents/product-information/ristempa-epar-product-information_nl.pdf)

norsk (NO) (1.08 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/no/documents/product-information/ristempa-epar-product-information_no.pdf)

polski (PL) (2.19 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/pl/documents/product-information/ristempa-epar-product-information_pl.pdf)

português (PT) (1.46 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/pt/documents/product-information/ristempa-epar-product-information_pt.pdf)

română (RO) (1.5 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/ro/documents/product-information/ristempa-epar-product-information_ro.pdf)

slovenčina (SK) (2.77 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/sk/documents/product-information/ristempa-epar-product-information_sk.pdf)

slovenščina (SL) (2.09 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/sl/documents/product-information/ristempa-epar-product-information_sl.pdf)

Suomi (FI) (1.42 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/fi/documents/product-information/ristempa-epar-product-information_fi.pdf)

svenska (SV) (1.48 MB - PDF)

**First published:**

16/04/2015

**Last updated:**

07/03/2018

[View](/sv/documents/product-information/ristempa-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0010 29/09/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

## Product details

Name of medicine Ristempa Active substance pegfilgrastim International non-proprietary name (INN) or common name pegfilgrastim Anatomical therapeutic chemical (ATC) code L03AA13

### Pharmacotherapeutic group

Immunostimulants

### Therapeutic indication

Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes)

## Authorisation details

EMA product number EMEA/H/C/003910 Marketing authorisation holder

Amgen Europe B.V.

Minervum 7061

Opinion adopted 26/02/2015 Marketing authorisation issued 13/04/2015 Withdrawal of marketing authorisation 28/09/2017 Revision 3

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Ristempa : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1.4 MB - PDF)

**First published:** 17/11/2015

**Last updated:** 07/03/2018

[View](/en/documents/procedural-steps-after/ristempa-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Ristempa : EPAR - Public assessment report

Adopted

Reference Number: EMA/187414/2015

English (EN) (1.7 MB - PDF)

**First published:** 16/04/2015

**Last updated:** 07/03/2018

[View](/en/documents/assessment-report/ristempa-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Ristempa

Adopted

Reference Number: EMA/CHMP/83846/2015

English (EN) (506.13 KB - PDF)

**First published:** 27/02/2015

**Last updated:** 07/03/2018

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-ristempa_en.pdf)

#### News on Ristempa

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 February 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-february-2015) 27/02/2015

**This page was last updated on** 07/03/2018

## Share this page

[Back to top](#main-content)